Navigation Links
Pharmaceutical Manufacturers - Europe
Date:8/30/2011

NEW YORK, Aug. 30, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Manufacturers - Europe

http://www.reportlinker.com/p0605696/Pharmaceutical-Manufacturers---Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

This register contains information about 3251 manufacturers of pharmaceuticals in Europe. The register includes the following details of the manufacturers:

* Company name

* Contact information

* Financial information*

* Number of employees*

The register is in Excel format. *When available

To order this report:

: Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program
2. Cumberland Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference in Boston
3. Pharmaceutical, Utility Companies Cautiously Add Social Media to Marketing Plans
4. Endo Pharmaceuticals to Present at the Stifel Nicolaus Annual Healthcare Conference
5. Masters Pharmaceutical, Inc. Announces DEA Registration for New Distribution Center
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2011
7. ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
8. 2nd Day of Testimony: Mainor Eglet Attorney Continues Questioning Teva Pharmaceuticals Vice President
9. Par Pharmaceutical To Acquire Anchen Pharmaceuticals
10. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
11. Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015  Encision Inc. (PK:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... June 30, 2015. The Company posted quarterly ... loss of $213 thousand, or $(0.02) per share. These ... a net loss of $202 thousand, or $(0.02) per ...
(Date:8/2/2015)... -- Mandatory takeover offer for the ... the "Company") is pleased to announce the signing of ... Marijan Han žeković to acquire his 63.3% holding (equivalent ... Croatian listed pharmaceutical business.   Dechra is ... €51.4 million for the entire share capital on a ...
(Date:7/31/2015)... More than 1,500 substance abuse prevention and treatment specialists ... Indianapolis Aug. 2-6 for Community Anti-Drug Coalitions ... The week-long training, held at the JW Marriott, will ... biggest public health challenges – youth drug use. ... intensive training opportunity, offering more than 70 half-day and ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2
... NVAX ), a clinical-stage vaccine company, announced today ... presenting at the ROTH 23rd Annual OC Growth Stock Conference ... The Ritz Carlton, Laguna Niguel, CA.  A live audio-only webcast ... website at www.novavax.com under Investors/Events, and a replay ...
... and LONDON, March 11, 2011 Tolerx, ... 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 ... of change in C-peptide at month 12 in patients ... Following preliminary review of the data, no new or ...
Cached Medicine Technology:Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 2Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 3Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 4
(Date:8/3/2015)... ... August 03, 2015 , ... A July 9 article from USA Today ... years, according to the American Dental Association. According to a study by the American ... 1.1 million in a single year to 2.2 million a year. Dentists and ADA ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has completed ... The acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities. ... regionally located business, as well as a large manufacturing hub in Noblesville, Indiana,” said ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Constantin Vasilica, 48 ... by tissue injury caused by diabetes after many years of suffering and using medications ... and he didn’t want to ask for extra time off or wait longer hours ...
(Date:8/3/2015)... (PRWEB) , ... August 03, ... ... (EMSI), a leading provider of medical information, risk management and investigative services, ... evolution and direction toward focused, expert information solutions that improve business outcomes ...
(Date:8/3/2015)... ... August 03, 2015 , ... Recent reports by the American Medical ... least once in their lives. Often time, low back and sciatic pain can happen ... only be managed clinically with powerful pain medication or spinal surgery. Dynamic Health ...
Breaking Medicine News(10 mins):Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2
... ... for the American Water Works Association’s (AWWA) 2010 Annual Conference & Exposition (ACE10), June ... ... American Water Works Association’s (AWWA) 2010 Annual Conference & Exposition (ACE10), June 20-24, in ...
... ... Services, CGI Federal, first contacted the Metropolitan Washington, DC Chapter of the Cystic ... his 2-month old daughter Melissa and 3-year old son Matthew had recently been ... children’s diagnosis, the average age of survival for a child with CF was ...
... ... is pleased to announce a new research grant program to fund investigations related to ... ... The American Orthopaedic Society for Sports Medicine (AOSSM), in partnership with Genzyme Biosurgery, ...
... ... is extending its reach to provide expanded resources, seminars, presentations and E-learning opportunities in ... Belleville, ... individuals on skin integrity, seating and positioning, as well as wheelchair cushion and medical ...
... , ... fewer employer sponsored plans and overwhelmed state agencies are possible causes for the increase ... ... families and individuals requested health insurance quotes from HealthInsuranceSort. The need for individual ...
... ... lead in water technology. , ... California (PRWEB) February 25, 2010 -- In a country with few natural resources, Israel is ... industry to help it weather the effects of the global meltdown., , ,Mouli Cohen, longtime ...
Cached Medicine News:Health News:AWWA Announces ACE10 Speakers 2Health News:Cystic Fibrosis Foundation Awards CGI Corporation of the Year 2Health News:Cystic Fibrosis Foundation Awards CGI Corporation of the Year 3Health News:New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery 2Health News:New Osteoarthritis Research Grant Program Initiated by AOSSM and Genzyme Biosurgery 3Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 2Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 3Health News:The ROHO Institute Announces Expansion of Continuing Education Programs 4Health News:HealthInsuranceSort.com Provides Record Number of Health Insurance Quotes in 2009 2Health News:Mouli Cohen on Innovating Israeli Water Technology 2
... Ultralight Jarrod Goggles have set the ... Nonslip soft silicone saddle nose bridge. ... better and lasts longer. Adjustable elastic ... without breakable plastic strap clips. 0.75 ...
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
QualCraft™ Radiation Protection Eyewear providex maximum comfort and eye protection! Lenses made of 0.75 mm leaded glass. Side shields of 0.30 mm leaded acrylic help seal out scatter radiation ...
Portable shields for your safety and convenience....
Medicine Products: